Better Patient Outcomes — Powered by Data and Digital

Digital transformation is increasingly essential in today’s life sciences industry. Pharma companies leverage data and advanced technologies to revolutionize medicine development, clinical and regulatory activities, ultimately improving patient outcomes and healthcare efficiency.

Data at The Heart of Pharma R&D Digital Transformation

Fueling every stage of pharma, from early research to market access:

• Early Research and Drug Discovery: Vast datasets—including genetic, proteomic, and clinical data—help identify promising drug candidates faster and more accurately. AI and machine learning models analyze millions of molecules to predict efficacy and toxicity, enabling pharma to fail earlier, faster, and cheaper, while helping to focus on the most viable compounds and accelerating the path to clinical trials.

• Safer, Smarter Clinical Trials: Using advanced analytics and real-world data, identify risks early, improving trial safety and efficiency. AI-driven data integration matches patients with optimal treatments and trials, enhancing efficacy and satisfaction. And comprehensive data analysis deepens insights into potential side effects, improving pharmacovigilance right from the start.

• Accelerated Market Access: Using data to drive regulatory automated content authoring or even data-driven submissions and strategies. Improving dossier compilation speed, compliance and reducing costs, thus bringing therapies to patients faster.

The Need for Embracing Standards and Interoperability

Industry initiatives like EMA’s electronic Product Information (ePI) pilots, ICH PQ CMC guidelines, and IDMP are driving standardization towards a seamless data exchange that is more transparent and helps a patient-centric ecosystem connecting pharma, regulators, healthcare providers, and patients.

Why It Matters

It’s about delivering better health outcomes, and data is a key enabler for it. There's a shared set of goals, such as:

• Shortening time from lab to patient

• Enhancing safety and treatment adherence

• Empowering patients and healthcare professionals with accessible information

• Enabling smarter clinical trials and regulatory processes

And pharma stands at a pivotal moment, where embracing data-driven digital transformation and interoperability will accelerate delivery of safer, more effective medicines—a win for patients, healthcare systems, the pharma industry, and society overall.

Let’s harness digital power to transform pharma and improve patient outcomes!